Literature DB >> 28072889

In-depth analysis of compartmentalization of HIV-1 matrix protein p17 in PBMC and plasma.

Marina Selleri1, Riccardo Dolcetti2,3, Francesca Caccuri4, Emanuela Giombini1, Gabriella Rozera1, Isabella Abbate1, Alessia Mammone1, Stefania Zanussi5, Debora Martorelli2, Simona Fiorentini4, Arnaldo Caruso4, Maria Rosaria Capobianchi1.   

Abstract

HIV-1 p17 plays an important role in the virus life-cycle and disease pathogenesis. Recent studies indicated a high heterogeneity of p17. A high number of insertions in the p17 carboxy-terminal region have been more frequently detected in patients with non-Hodgkin lymphoma (NHL), suggesting a role of altered p17 in lymphomagenesis. Based on p17 heterogeneity, possible PBMC/plasma compartmentalization of p17 variants was explored by ultra-deep pyrosequencing in five NHL patients. The high variability of p17 with insertions at the carboxy-terminal region was confirmed in plasma and observed for the first time in proviral genomes. Quasispecies compartmentalization was evident in 4/5 patients. Further studies are needed to define the possible role of p17 quasispecies compartmentalization in lymphomagenesis.

Entities:  

Keywords:  Compartmentalization; HIV-1 matrix protein; Non-Hodgkin lymphoma; Ultra-deep pyrosequencing; Viral quasispecies; p17

Mesh:

Substances:

Year:  2017        PMID: 28072889

Source DB:  PubMed          Journal:  New Microbiol        ISSN: 1121-7138            Impact factor:   2.479


  2 in total

1.  HIV-1 mutants expressing B cell clonogenic matrix protein p17 variants are increasing their prevalence worldwide.

Authors:  Francesca Caccuri; Serena Messali; Alberto Zani; Giovanni Campisi; Marta Giovanetti; Stefania Zanussi; Emanuela Vaccher; Silvia Fabris; Antonella Bugatti; Emanuele Focà; Francesco Castelli; Massimo Ciccozzi; Riccardo Dolcetti; Robert C Gallo; Arnaldo Caruso
Journal:  Proc Natl Acad Sci U S A       Date:  2022-06-28       Impact factor: 12.779

2.  HIV-1 matrix protein p17 and its variants promote human triple negative breast cancer cell aggressiveness.

Authors:  Francesca Caccuri; Francesca Giordano; Ines Barone; Pietro Mazzuca; Cinzia Giagulli; Sebastiano Andò; Arnaldo Caruso; Stefania Marsico
Journal:  Infect Agent Cancer       Date:  2017-09-25       Impact factor: 2.965

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.